Started by a woman who needed better answers

Unravel Health turns a decade of University of Glasgow biosensor research into a lab you can keep at home. London and Glasgow.

Our story

Co-founder and CEO Veronika Bridgman lives with PMOS, formerly known as PCOS. Years before Unravel, she built her own hormone tracker because one-off tests could not show what her body was doing day to day. Micro Lab grew out of that need: real hormone readings, taken as often as the question requires.

“Fifteen years ago I built my own hormone tracker to manage PMOS because a blood test told me almost nothing.”
Veronika Bridgman, co-founder and CEO, in FemTech Insider
“Reading hormones in saliva outside a lab has been our Everest.”
Veronika Bridgman, in BusinessCloud

The team

Product, commercial, clinical and sensor science in one room, with the inventors of the core technology.

Veronika Bridgman

Veronika Bridgman

Co-founder and CEO

Product and data leader who created her own hormone-tracking systems over 15 years ago.

Liza Levy

Liza Levy

Co-founder

Commercial leader who scaled a healthtech company from early stage to IPO.

Dr Alexandra Oti

Dr Alexandra Oti

Co-founder

Internal Medicine doctor and biomedical engineer translating hormone data into better care.

Prof David Cumming

Prof David Cumming

Fractional CSO, Hardware

Inventor of Unravel's core sensor technology and a leader in nanoengineering.

Dr Chunxiao Hu

Dr Chunxiao Hu

Fractional CSO, Biosensor

Biosensor and assay expert, University of Glasgow lecturer and co-inventor of the platform.

Dr Shadi Karimi

Dr Shadi Karimi

Senior Development Scientist

Microfluidics engineer leading the saliva cartridge development.

Mia Richell

Mia Richell, PhD

Research Lead

Leads large-scale studies, ethics and patient involvement with UK academic partners.

£2.5M seed to take Micro Lab to early access

Announced in October 2026, the round is led by Conduit EIS Impact Fund and Wrightwood, with Leo Capital, Embryo Ventures, Hermesa and returning investor Zinc.

Use of funds
External equivalency studies, additional markers and the start of regulatory approval
Earlier support
More than £1M from Innovate UK, the Medical Research Council, SBRI, strategic angels and Zinc
IP
Three granted patents
Next milestone
First early access devices in 2027 through pharmacy, digital health and clinical research partners

Press

For interviews, images and the prototype story, write to info@unravel.health.